lonodelestat (POL6014) - Santhera, Cold Spring Harbor Laboratory
Lonodelestat: Completion of P1b part of P1b/2a trial (NCT03748199) for cystic fibrosis in Q4 2020 (Santhera) - Dec 22, 2020 - Corporate Presentation: Data from P1b/2a trial for cystic fibrosis in early 2021 
P1/2 data • Trial status Cystic Fibrosis
http://www.santhera.com/assets/files/content/presentations/2020-11-18_Santhera_Presentation_final_ext.pdf
 
Dec 22, 2020
 
 
1f3f7b25-30a2-4505-8acb-4128f651fbac.png